Research Article
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion
Figure 1
Chemical structures of edaravone (EDV) and edaravone derivative containing NO-donor furoxan moiety (NO-EDV).
(a) |
(b) |